Biotech Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024 October 22, 2024
Biotech MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum October 20, 2024
Biotech 111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow October 18, 2024
Biotech Sunvozertinib Granted Breakthrough Therapy Designation by China CDE for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations October 15, 2024
Biotech Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma October 15, 2024